Accumulation of cells with short telomeres is associated with impaired zinc homeostasis and inflammation in old hypertensive participants

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 64, Issue 7, 2009, Pages 745-751

  Cipriano, Catia ^a   Tesei, Silvia ^a   Malavolta, Marco ^a   Giacconi, Robertina ^a   Muti, Elisa ^a   Costarelli, Laura ^a   Piacenza, Francesco ^b   Pierpaoli, Sara ^a   Galeazzi, Roberta ^a   Blasco, Maria ^c   Vera, Elsa ^c   Canela, Andres ^c   Lattanzio, Fabrizia ^a   Mocchegiani, Eugenio ^a  

^a INRCA   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c Centro Nacional de Investigaciones Oncológicas   (Spain)

Author keywords

Cell senescence; Hypertension; Inflammation; Metallothioneins; Zinc

Indexed keywords

METALLOTHIONEIN; ZINC;

ADULT; AGED; AGING; ARTICLE; CARDIOVASCULAR DISEASE; CELL LEVEL; CONTROLLED STUDY; FEMALE; HOMEOSTASIS; HUMAN; HYPERTENSION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TELOMERE; TELOMERE SHORTENING; ZINC METABOLISM; BODY MASS; CASE CONTROL STUDY; CELL AGING; DOWN REGULATION; GENETICS; METABOLISM; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; QUESTIONNAIRE; RISK FACTOR; SMOKING;

AGED; AGED, 80 AND OVER; AGING; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CELL AGING; DOWN-REGULATION; HOMEOSTASIS; HUMANS; HYPERTENSION; INFLAMMATION; METALLOTHIONEIN; MIDDLE AGED; OBESITY; QUESTIONNAIRES; RISK FACTORS; SMOKING; TELOMERE; ZINC;

EID: 67649657879     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/glp048     Document Type: Article

References (40)

1. Allsopp RC, Vaziri H, Patterson C, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci U S A. 1992;89:10114-10118.
2. Kappei D, Londono-Vallejo JA. Telomere length inheritance and aging. Mech Ageing Dev. 2008;129:17-26.
3. Farzaneh-Far R, Cawthon RM, Na B, Browner WS, Schiller NB, Whooley MA. Prognostic value of leukocyte telomere length in patients with stable coronary artery disease:data from the Heart and Soul Study. Arterioscler Thromb Vasc Biol. 2008;28:1379-1384.
4. Fuster JJ, Andrés V. Telomere biology and cardiovascular disease. Circ Res. 2006;99:1167-1180.
5. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease. Prolonged differences in blood pressure:prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335:765-774.
6. Jeanclos E, Schork NJ, Kyvik KO, Kimura M, Skurnick JH, Aviv A. Telomere length inversely correlates with pulse pressure and is highly familial. Hypertension. 2000;36:195-200.
7. Demissie S, Levy D, Benjamin EJ, et al. Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham Heart Study. Aging Cell. 2006;5:325-330.
8. Braunwald E. Biomarkers in heart failure. N Engl J Med. 2008;358: 2148-2159.
9. Beattie JH, Kwun IS. Is zinc deficiency a risk factor for atherosclerosis? Br J Nutr. 2004;91:177-181.
10. Giacconi R, Bonfigli AR, Testa R, et al. +647 A/C and +1245 MT1A polymorphisms in the susceptibility of diabetes mellitus and cardiovascular complications. Mol Genet Metab. 2008;94:98-104.
11. Maret W, Krezel A. Cellular zinc and redox buffering capacity of metallothionein/thionein in health and disease. Mol Med. 2007;13: 371-375.
12. Maret W, Vallee BL. Thiolate ligands in metallothionein confer redox activity on zinc clusters. Proc Natl Acad Sci U S A. 1998;98: 2317-2322.
13. Giacconi R, Muti E, Malavolta M, et al. The +838 C/G MT2A polymorphism, metals, and the inflammatory/immune response in carotid artery stenosis in elderly people. Mol Med. 2007;13:388-395.
14. Costarelli L, Muti E, Malavolta M, et al. Modulation of genes involved in zinc homeostasis in old low-grade atherosclerotic patients under effects of HMG-CoA reductase inhibitors. Rejuvenation Res. 2008;11:287-291.
15. Mocchegiani E, Giacconi R, Cipriano C, et al. Zinc, metallothioneins and longevity effect of zinc supplementation:zincage study. Ann N Y Acad Sci. 2007;1119:129-146.
16. Mocchegiani E, Muzzioli M, Giacconi R, et al. Metallothioneins/PARP-1/IL- 6 interplay on natural killer cell activity in elderly:parallelism with nonagenarians and old infected humans. Effect of zinc supply. Mech Ageing Dev. 2003;124:459-468.
17. Malavolta M, Cipriano C, Costarelli L, et al. Metallothionein down-regulation in very old age:a phenomenon associated with cellular senescence? Rejuvenation Res. 2008;11:455-459.
18. Canela A, Vera E, Klatt P, Blasco MA. High-throughput telomere length quantification by FISH and its application to human population studies. Proc Natl Acad Sci U S A. 2007;104:5300-5305.
19. Yurkow EJ, Makhijani PR. Flow cytometric determination of metallothionein levels in human peripheral blood lymphocytes:utility in environmental exposure assessment. J Toxicol Environ Health A. 1998;54:445-457.
20. Malavolta M, Piacenza F, Costarelli L, et al. Combining UHR-SEC-HPLC-ICP-MS with flow cytometry to quantify metallothioneins and to study zinc homeostasis in human PBMC. J Anal At Spectrom. 2007;22:1193-1198.
21. Malavolta M, Costarelli L, Giacconi R, et al. Single and three-color flow cytometry assay for intracellular zinc ion availability in human lymphocytes with zinpyr-1 and double immunofluorescence:relationship with metallothioneins. Cytometry A. 2006;69:1043-1053.
22. Burdette SC, Walkup GK, Spingler B, Tsien RY, Lippard SJ. Fluorescent sensors for Zn(2+) based on a fluorescein platform: synthesis, properties and intracellular distribution. J Am Chem Soc. 2001;123: 7831-7841.
23. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell. 2005;120:513-522.
24. Aubert G, Lansdorp PM. Telomeres and aging. Physiol Rev. 2008; 88:557-579.
25. Wikby A, Nilsson BO, Forsey R, et al. The immune risk phenotype is associated with IL-6 in the terminal decline stage: findings from the Swedish NONA immune longitudinal study of very late life functioning. Mech Ageing Dev. 2006;127:695-704.
26. Rufer N, Brümmendorf TH, Kolvraa S, et al. Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood. J Exp Med. 1999;190:157-167.
27. Schmid I, Dagarag MD, Hausner MA, et al. Simultaneous flow cytometric analysis of two cell surface markers, telomere length, and DNA content. Cytometry. 2002;49:96-105.
28. Effros RB, Dagarag M, Spaulding C, Man J. The role of CD8+ T-cell replicative senescence in human aging. Immunol Rev. 2005;205: 147-157.
29. Cawthon RM, Smith KR, O'Brien E, Sivatchenko A, Kerber RA. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet. 2003;361:393-395.
30. Zhang C. The role of inflammatory cytokines in endothelial dysfunction. Basic Res Cardiol. 2008;103:398-406.
31. Carrero JJ, Stenvinkel P, Fellström B, et al. Telomere attrition is associated with inflammation, low fetuin-A levels and high mortality in prevalent haemodialysis patients. J Intern Med. 2008;263:302-312.
32. Kannel WB. Blood pressure as a cardiovascular risk factor:prevention and treatment. J Am Med Assoc. 1996;275:1571-1576.
33. Lowe GD. Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease. J Thromb Haemost. 2005;3: 1618-1627.
34. Franceschi C, Bonafè M, Valensin S, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000; 908:244-254.
35. Mocchegiani E, Costarelli L, Giacconi R, Cipriano C, Muti E, Malavolta M. Zinc-binding proteins (metallothionein and alpha-2 macroglobulin) and immunosenescence. Exp Gerontol. 2006;41: 1094-1107.
36. Liuzzi JP, Lichten LA, Rivera S, et al. Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response. Proc Natl Acad Sci U S A. 2005;102:6843-6848.
37. Besecker B, Bao S, Bohacova B, Papp A, Sadee W, Knoell DL. The human zinc transporter SLC39A8 (Zip8) is critical in zinc-mediated cytoprotection in lung epithelia. Am J Physiol Lung Cell Mol Physiol. 2008;294:1127-1136.
38. Mocchegiani E, Giacconi R, Muti E, et al. Zinc, immune plasticity, aging, and successful aging:role of metallothionein. Ann N Y Acad Sci. 2004;1019:127-134.
39. Andree KB, Kim J, Kirschke CP, et al. Investigation of lymphocyte gene expression for use as biomarkers for zinc status in humans. J Nutr. 2004;134:1716-1723.
40. Nemoto K, Kondo Y, Himeno S, et al. Modulation of telomerase activity by zinc in human prostatic and renal cancer cells. Biochem Pharmacol. 2000;59:401-405.